Buch, Englisch, 269 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 646 g
Reihe: Current Clinical Urology
Buch, Englisch, 269 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 646 g
Reihe: Current Clinical Urology
ISBN: 978-1-58829-155-4
Verlag: Humana Press
A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
1 Prostate Anatomy and Causative Theories, Pathophysiology, and Natural History of Benign Prostatic Hyperplasia.- 2 The Definition of Benign Prostatic Hyperplasia: Epidemiology and Prevalence.- 3 Pathophysiology, Diagnosis, and Treatment of the Postobstructive Diuresis.- 4 Urodynamics and the Evaluation of Male Lower Urinary Tract Symptoms.- 5 ?-Adrenergic Antagonists in the Treatment of Benign Prostatic Hypertrophy-Associated Lower Urinary Tract Symptoms.- 6 5?-Reductase Inhibitors.- 7 Transurethral Needle Ablation of the Prostate.- 8 Transurethral Microwave Thermotherapy.- 9 Transurethral Incision of the Prostate.- 10 Interstitial Laser Coagulation and High-Intensity Focused Ultrasound for the Treatment of Benign Prostatic Hyperplasia.- 11 Transurethral Resection of the Prostate.- 12 Transurethral Vaporization of the Prostate.- 13 Treatment of Benign Prostatic Hyperplasia with Ethanol Injections, Water-Induced Thermotherapy, and Prostatic Urethral Luminal Stents.- 14 Suprapubic Transvesical Prostatectomy and Simple Perineal Prostatectomy for the Treatment of Benign Prostatic Hyperplasia.
